All news

Huntington Sec starts Sabra Healthcare REIT at strong-buy

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Huntington Sec initiated coverage on Sabra Healthcare REIT (NASDAQ:SBRA) with a strong-buy rating. The stock carries a Moderate Buy average rating and a consensus price target of $21.50, with six buys, nine holds and one sell. Sabra's Q3 2026 results missed EPS estimates but beat revenue expectations, and the company raised 2026 guidance.

Read original source

SBRA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.